The historic rise of Viagra has long been a symbol of pharmaceutical success, however its position within the broader sector now triggers questions about future gains. Alternative versions are eroding exclusivity , leading to anxieties that investing in companies closely tied to Viagra's previous standing could be a problematic strategy, especially